Currently, a typical treatment regimen for patients, the transplant surgery and a minoxidil or finasteride – dutasteride or maybe. A word of caution with all current medical options, the potential for adverse side effects. Alternatively, the last ten years a series of hair loss treatments containing natural products have been developed and secondary plant substances. These usually have an excellent safety profile, but with rare exceptions, they remain largelynot peer-reviewed data.

The development of effective and safe treatment for hair loss remains a difficult task. While the genetic basis of hair loss, also called androgenetic alopecia (AGA), is not yet fully determined, it is clearly a complex genetic disorder in which multiple genes and environmental factors contribute in ways hormonal phenotype. So far, the modulation of DHT 5-alpha reductase (5-AR) blockaderemains the main target for medical therapy shown to slow the progression of AGA.

monitored before, in a small study IRB, we liposterolic the effectiveness of Serenoa repens (LSESr) tested the extract, Saw Palmetto Extract, alias, alias Permixon and its glycoside, β-sitosterol in patients with AGA, and showed a very positive response to treatment. The publication is founded in 2002, the effectiveness of natural inhibitors against AGA 5-AR for the first time.LSESr that contains the fruit of saw palmetto tree springs a real pot of bioactive fatty acids and sterols including stigmasterol, campesterol and β-sitosterol.

Saw Palmetto first came into widespread clinical use in Europe as a treatment proven safe and effective for benign prostatic hyperplasia (BPH). In particular, a direct comparison between LSESr against finasteride, it was reported that a 3 times greater LSESr shown inhibition of 5-AR in in vitro test. ButLight blocking 5-AR treatment is only one aspect of the AGA. Chronic inflammation of the molecular and cellular level recognized as the final common pathway of many systemic diseases and degenerative diseases, including skin changes. It 'was also observed that inflammation plays a factor common pattern hair loss. Histologically sustainable follicular inflammation is a discovery known AGA.

In our recent study, we wanted to test a proprietaryLSESr formulation with L-carnitine and thioctic acid (TA) in a well-validated diagnostic representing HF keratinocytes in vitro, in particular, LPS-stimulated HaCaT cells. Our logic is based on a finding that L-carnitine, and TA LSESr operate by different base, but potentially with others, the biochemical and molecular features. For example, gather the evidence indicates that L-carnitine may play an important role in the prevention and treatment of many diseases, game andProtection against damage caused by accelerated aging oxygen free radicals, inflammation and glycation (non-enzymatic glycosylation).

One line of research suggests that carnitine may Matrix Have the ability to promote hair growth in vitro by increasing energy supplies, growing and consumption of energy-anagen hair. Similarly, the TA hours as a compound with many functions biological, such as modulation of inflammatory events are recognized pathogensincluding leather. Our hypothesis is based on more effective combination of anti-inflammatory compounds with 5-AR inhibitors.

We tested for changes in gene expression in a range of well-characterized markers of inflammation and found that our connection test statistically significant anti-inflammatory properties in vitro demonstrated. For example, we found that the expression of the actual composition of LPS-activated chemokine CCL17 and leukotrienes CXCL6 deleted (LT) B4. Overexpression of each of these markers was previously observed in a context of inflammation and apoptosis.

The recognition that inflammation contributes to a wide range of diseases, including the skin and hair, it is our opinion that the blockade of inflammation of hair follicles sensitive Avenue is a valid and potentially new therapeutic. The result improved opportunities to use anti-inflammatory compounds with 5-AR inhibitorsavailable for examination in the setting of transplant surgery. Since the clinical success rate to the treatment of AGA is only limited to androgen blockade, there is a huge need for doctors to patients, particularly those undergoing surgery transplantation, therapy response stream.